Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Ciprofol TIVA in Pediatric Tonsillectomy
NCT07118579Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Sep 2025
- Primary completion
- Aug 2026
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam, ciprofol in tonsillitis, adenoid hypertrophy, sponsored by Tongji Hospital. Started Sep 2025; status: recruiting.
02
Drugs
remimazolamciprofol
03
Conditions
tonsillitisadenoid hypertrophy
Beyond the preview
Go deeper on NCT07118579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07118579.